SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5ll7'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1FKP_A_NVPA999_1 (HIV-1 RT, A-CHAIN)	5ll7	BETA-LACTAMASE (Escherichia coli)	5 / 11	LEU A 285 VAL A 46 VAL A 57 TYR A 60 LEU A 36	None	1.28A	1fkpA-5ll7A: undetectable	1fkpA-5ll7A: 10.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1FXH_B_PACB1001_0 (PENICILLIN ACYLASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	4 / 7	PHE A 207 SER A 189 ALA A 198 ILE A 155	None None EDO A 302 (-3.5A) EDO A 302 (-4.3A)	1.05A	1fxhA-5ll7A: undetectable 1fxhB-5ll7A: undetectable	1fxhA-5ll7A: undetectable 1fxhB-5ll7A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1GHM_A_CEDA1_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	6 / 12	SER A 70 LYS A 73 SER A 130 ASN A 132 LYS A 234 GLY A 236	6YV A 301 (-1.7A) 6YV A 301 ( 3.8A) 6YV A 301 (-2.6A) 6YV A 301 (-3.7A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A)	0.44A	1ghmA-5ll7A: 37.7	1ghmA-5ll7A: 13.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1I2W_A_CFXA1300_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	8 / 12	SER A 70 LYS A 73 SER A 130 ASN A 132 GLU A 166 THR A 216 LYS A 234 GLY A 236	6YV A 301 (-1.7A) 6YV A 301 ( 3.8A) 6YV A 301 (-2.6A) 6YV A 301 (-3.7A) 6YV A 301 (-2.7A) 6YV A 301 ( 4.2A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A)	0.48A	1i2wA-5ll7A: 41.5	1i2wA-5ll7A: 18.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1I2W_B_CFXB2300_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	7 / 12	SER A 70 LYS A 73 SER A 130 ASN A 132 GLU A 166 GLY A 236 ARG A 220	6YV A 301 (-1.7A) 6YV A 301 ( 3.8A) 6YV A 301 (-2.6A) 6YV A 301 (-3.7A) 6YV A 301 (-2.7A) 6YV A 301 ( 4.0A) 6YV A 301 ( 3.7A)	1.07A	1i2wB-5ll7A: 41.8	1i2wB-5ll7A: 18.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1I2W_B_CFXB2300_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	7 / 12	SER A 70 LYS A 73 SER A 130 ASN A 132 GLU A 166 THR A 216 GLY A 236	6YV A 301 (-1.7A) 6YV A 301 ( 3.8A) 6YV A 301 (-2.6A) 6YV A 301 (-3.7A) 6YV A 301 (-2.7A) 6YV A 301 ( 4.2A) 6YV A 301 ( 4.0A)	0.44A	1i2wB-5ll7A: 41.8	1i2wB-5ll7A: 18.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1S1X_A_NVPA999_1 (REVERSE TRANSCRIPTASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	4 / 8	LEU A 36 VAL A 46 GLY A 45 LEU A 285	None	0.81A	1s1xA-5ll7A: undetectable	1s1xA-5ll7A: 10.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1YMX_A_CFXA1001_1 (BETA-LACTAMASE CTX-M-9)	5ll7	BETA-LACTAMASE (Escherichia coli)	9 / 12	SER A 70 LYS A 73 SER A 130 ASN A 132 GLU A 166 ASN A 170 THR A 216 LYS A 234 GLY A 236	6YV A 301 (-1.7A) 6YV A 301 ( 3.8A) 6YV A 301 (-2.6A) 6YV A 301 (-3.7A) 6YV A 301 (-2.7A) 6YV A 301 (-2.9A) 6YV A 301 ( 4.2A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A)	0.71A	1ymxA-5ll7A: 42.9	1ymxA-5ll7A: 17.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1YMX_B_CFXB1002_1 (BETA-LACTAMASE CTX-M-9)	5ll7	BETA-LACTAMASE (Escherichia coli)	8 / 12	SER A 70 LYS A 73 SER A 130 ASN A 132 GLU A 166 ASN A 170 LYS A 234 GLY A 236	6YV A 301 (-1.7A) 6YV A 301 ( 3.8A) 6YV A 301 (-2.6A) 6YV A 301 (-3.7A) 6YV A 301 (-2.7A) 6YV A 301 (-2.9A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A)	0.68A	1ymxB-5ll7A: 43.1	1ymxB-5ll7A: 17.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2CIZ_A_ACTA1320_0 (CHLOROPEROXIDASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	4 / 6	ALA A 286 PHE A 33 ILE A 44 VAL A 263	None	0.97A	2cizA-5ll7A: undetectable	2cizA-5ll7A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIM_J_CHDJ60_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART)	5ll7	BETA-LACTAMASE (Escherichia coli)	4 / 5	ARG A 96 MET A 117 THR A 118 LEU A 122	None	1.31A	2eimJ-5ll7A: undetectable	2eimJ-5ll7A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIM_W_CHDW1060_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART)	5ll7	BETA-LACTAMASE (Escherichia coli)	4 / 5	ARG A 96 MET A 117 THR A 118 LEU A 122	None	1.35A	2eimW-5ll7A: undetectable	2eimW-5ll7A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VCV_D_ASDD1224_1 (GLUTATHIONE S-TRANSFERASE A3)	5ll7	BETA-LACTAMASE (Escherichia coli)	5 / 9	PRO A 145 LEU A 162 LEU A 139 ALA A 135 PHE A 72	None	1.13A	2vcvD-5ll7A: undetectable	2vcvD-5ll7A: 17.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VCV_E_ASDE1224_1 (GLUTATHIONE S-TRANSFERASE A3)	5ll7	BETA-LACTAMASE (Escherichia coli)	5 / 9	PRO A 145 LEU A 162 LEU A 139 ALA A 135 PHE A 72	None	1.09A	2vcvE-5ll7A: undetectable	2vcvE-5ll7A: 17.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VCV_H_ASDH1224_1 (GLUTATHIONE S-TRANSFERASE A3)	5ll7	BETA-LACTAMASE (Escherichia coli)	5 / 9	PRO A 145 LEU A 162 LEU A 139 ALA A 135 PHE A 72	None	1.07A	2vcvH-5ll7A: undetectable	2vcvH-5ll7A: 17.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3CLB_B_TMQB612_1 (DHFR-TS)	5ll7	BETA-LACTAMASE (Escherichia coli)	5 / 12	ALA A 185 ASP A 157 MET A 152 PHE A 160 TYR A 264	None	1.18A	3clbB-5ll7A: undetectable	3clbB-5ll7A: 11.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HLW_A_CE3A301_1 (CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	7 / 12	LYS A 73 SER A 130 ASN A 132 ASN A 170 THR A 216 LYS A 234 GLY A 236	6YV A 301 ( 3.8A) 6YV A 301 (-2.6A) 6YV A 301 (-3.7A) 6YV A 301 (-2.9A) 6YV A 301 ( 4.2A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A)	0.72A	3hlwA-5ll7A: 43.0	3hlwA-5ll7A: 16.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HLW_B_CE3B302_1 (CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	7 / 12	SER A 130 ASN A 132 ASN A 170 THR A 216 LYS A 234 THR A 235 GLY A 236	6YV A 301 (-2.6A) 6YV A 301 (-3.7A) 6YV A 301 (-2.9A) 6YV A 301 ( 4.2A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A)	0.66A	3hlwB-5ll7A: 43.0	3hlwB-5ll7A: 16.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HUO_A_PNNA300_0 (CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	6 / 12	LYS A 73 ASN A 132 ASN A 170 LYS A 234 THR A 235 GLY A 236	6YV A 301 ( 3.8A) 6YV A 301 (-3.7A) 6YV A 301 (-2.9A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A)	0.58A	3huoA-5ll7A: 42.8	3huoA-5ll7A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HUO_A_PNNA302_0 (CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	5 / 6	THR A 51 LEU A 195 GLY A 196 ALA A 257 PRO A 258	None	0.24A	3huoA-5ll7A: 42.8	3huoA-5ll7A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HUO_B_PNNB301_0 (CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	5 / 12	LYS A 73 ASN A 132 ASN A 170 LYS A 234 GLY A 236	6YV A 301 ( 3.8A) 6YV A 301 (-3.7A) 6YV A 301 (-2.9A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A)	0.58A	3huoB-5ll7A: 42.9	3huoB-5ll7A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MZE_A_CFXA364_1 (D-ALANYL-D-ALANINE CARBOXYPEPTIDASE DACA)	5ll7	BETA-LACTAMASE (Escherichia coli)	6 / 12	SER A 70 ASN A 132 LEU A 167 THR A 235 GLY A 236 ARG A 220	6YV A 301 (-1.7A) 6YV A 301 (-3.7A) None 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A) 6YV A 301 ( 3.7A)	0.87A	3mzeA-5ll7A: 21.3	3mzeA-5ll7A: 11.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MZE_A_CFXA364_1 (D-ALANYL-D-ALANINE CARBOXYPEPTIDASE DACA)	5ll7	BETA-LACTAMASE (Escherichia coli)	6 / 12	SER A 70 LYS A 73 ASN A 132 THR A 235 GLY A 236 ARG A 220	6YV A 301 (-1.7A) 6YV A 301 ( 3.8A) 6YV A 301 (-3.7A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A) 6YV A 301 ( 3.7A)	0.73A	3mzeA-5ll7A: 21.3	3mzeA-5ll7A: 11.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NY4_A_SMXA308_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	9 / 12	SER A 70 SER A 130 ASN A 170 THR A 216 ARG A 220 LYS A 234 THR A 235 GLY A 236 THR A 237	6YV A 301 (-1.7A) 6YV A 301 (-2.6A) 6YV A 301 (-2.9A) 6YV A 301 ( 4.2A) 6YV A 301 ( 3.7A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A) 6YV A 301 (-3.6A)	0.30A	3ny4A-5ll7A: 39.9	3ny4A-5ll7A: 19.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3Q07_A_WPPA300_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	6 / 12	LYS A 73 SER A 130 ASN A 132 ASN A 170 LYS A 234 GLY A 236	6YV A 301 ( 3.8A) 6YV A 301 (-2.6A) 6YV A 301 (-3.7A) 6YV A 301 (-2.9A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A)	0.62A	3q07A-5ll7A: 42.8	3q07A-5ll7A: 16.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3Q07_B_WPPB400_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	6 / 12	LYS A 73 SER A 130 ASN A 132 ASN A 170 LYS A 234 GLY A 236	6YV A 301 ( 3.8A) 6YV A 301 (-2.6A) 6YV A 301 (-3.7A) 6YV A 301 (-2.9A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A)	0.60A	3q07B-5ll7A: 43.0	3q07B-5ll7A: 16.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SH8_A_CEDA1_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	6 / 12	SER A 70 SER A 130 ASN A 132 LYS A 234 THR A 235 GLY A 236	6YV A 301 (-1.7A) 6YV A 301 (-2.6A) 6YV A 301 (-3.7A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A)	0.49A	3sh8A-5ll7A: 40.6	3sh8A-5ll7A: 17.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SH8_B_CEDB1_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	6 / 12	SER A 70 LYS A 73 SER A 130 ASN A 132 LYS A 234 GLY A 236	6YV A 301 (-1.7A) 6YV A 301 ( 3.8A) 6YV A 301 (-2.6A) 6YV A 301 (-3.7A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A)	0.58A	3sh8B-5ll7A: 40.2	3sh8B-5ll7A: 17.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EUZ_A_MEMA401_1 (CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1)	5ll7	BETA-LACTAMASE (Escherichia coli)	10 / 12	LYS A 73 SER A 130 ASN A 132 LEU A 167 ASN A 170 THR A 216 LYS A 234 THR A 235 GLY A 236 THR A 237	6YV A 301 ( 3.8A) 6YV A 301 (-2.6A) 6YV A 301 (-3.7A) None 6YV A 301 (-2.9A) 6YV A 301 ( 4.2A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A) 6YV A 301 (-3.6A)	0.45A	4euzA-5ll7A: 45.4	4euzA-5ll7A: 22.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FH2_A_0RNA303_1 (BETA-LACTAMASE SHV-1)	5ll7	BETA-LACTAMASE (Escherichia coli)	5 / 10	SER A 130 ASN A 132 LYS A 234 THR A 235 GLY A 236	6YV A 301 (-2.6A) 6YV A 301 (-3.7A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A)	0.41A	4fh2A-5ll7A: 35.2	4fh2A-5ll7A: 16.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4KCN_B_MTLB805_0 (NITRIC OXIDE SYNTHASE, BRAIN)	5ll7	BETA-LACTAMASE (Escherichia coli)	4 / 6	ARG A 161 ASP A 176 ASP A 163 ARG A 178	None	1.39A	4kcnB-5ll7A: undetectable	4kcnB-5ll7A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LB2_A_DM5A601_1 (SERUM ALBUMIN)	5ll7	BETA-LACTAMASE (Escherichia coli)	4 / 7	LEU A 122 VAL A 119 PRO A 94 TYR A 112	None	1.01A	4lb2A-5ll7A: undetectable	4lb2A-5ll7A: 9.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4N9K_A_CEDA301_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	7 / 12	SER A 70 SER A 130 ASN A 132 ASN A 170 LYS A 234 THR A 235 GLY A 236	6YV A 301 (-1.7A) 6YV A 301 (-2.6A) 6YV A 301 (-3.7A) 6YV A 301 (-2.9A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A)	0.50A	4n9kA-5ll7A: 42.0	4n9kA-5ll7A: 17.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4N9K_B_CEDB301_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	7 / 12	SER A 70 SER A 130 ASN A 132 ASN A 170 LYS A 234 THR A 235 GLY A 236	6YV A 301 (-1.7A) 6YV A 301 (-2.6A) 6YV A 301 (-3.7A) 6YV A 301 (-2.9A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A)	0.48A	4n9kB-5ll7A: 42.0	4n9kB-5ll7A: 17.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PB1_A_RBVA501_1 (NUPC FAMILY PROTEIN)	5ll7	BETA-LACTAMASE (Escherichia coli)	5 / 12	GLY A 74 ALA A 77 LEU A 148 ASN A 136 ASN A 132	None None None None 6YV A 301 (-3.7A)	1.37A	4pb1A-5ll7A: undetectable	4pb1A-5ll7A: 13.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PM5_A_CE3A301_1 (BETA-LACTAMASE CTX-M-14)	5ll7	BETA-LACTAMASE (Escherichia coli)	7 / 12	SER A 130 ASN A 132 ASN A 170 THR A 216 LYS A 234 THR A 235 GLY A 236	6YV A 301 (-2.6A) 6YV A 301 (-3.7A) 6YV A 301 (-2.9A) 6YV A 301 ( 4.2A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A)	0.65A	4pm5A-5ll7A: 43.1	4pm5A-5ll7A: 16.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PM5_A_CE3A301_1 (BETA-LACTAMASE CTX-M-14)	5ll7	BETA-LACTAMASE (Escherichia coli)	6 / 12	SER A 130 THR A 216 LYS A 234 THR A 235 GLY A 236 GLY A 239	6YV A 301 (-2.6A) 6YV A 301 ( 4.2A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A) None	0.88A	4pm5A-5ll7A: 43.1	4pm5A-5ll7A: 16.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PM7_A_CE3A301_1 (BETA-LACTAMASE CTX-M-14)	5ll7	BETA-LACTAMASE (Escherichia coli)	7 / 12	LYS A 73 SER A 130 ASN A 132 ASN A 170 THR A 216 LYS A 234 GLY A 236	6YV A 301 ( 3.8A) 6YV A 301 (-2.6A) 6YV A 301 (-3.7A) 6YV A 301 (-2.9A) 6YV A 301 ( 4.2A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A)	0.71A	4pm7A-5ll7A: 43.0	4pm7A-5ll7A: 16.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PM9_A_CE3A301_1 (BETA-LACTAMASE CTX-M-14)	5ll7	BETA-LACTAMASE (Escherichia coli)	7 / 12	SER A 130 ASN A 132 ASN A 170 THR A 216 LYS A 234 THR A 235 GLY A 236	6YV A 301 (-2.6A) 6YV A 301 (-3.7A) 6YV A 301 (-2.9A) 6YV A 301 ( 4.2A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A)	0.63A	4pm9A-5ll7A: 42.6	4pm9A-5ll7A: 16.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Q0B_C_NVPC901_1 (HIV-1 REVERSE TRANSCRIPTASE, P66 SUBUNIT)	5ll7	BETA-LACTAMASE (Escherichia coli)	5 / 9	LEU A 285 VAL A 46 VAL A 57 TYR A 60 LEU A 36	None	1.32A	4q0bC-5ll7A: undetectable	4q0bC-5ll7A: 9.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ZXI_A_GLYA1402_0 (TYROCIDINE SYNTHETASE 3)	5ll7	BETA-LACTAMASE (Escherichia coli)	4 / 7	ASP A 246 ILE A 221 GLY A 232 THR A 235	None None None 6YV A 301 (-3.6A)	1.16A	4zxiA-5ll7A: undetectable	4zxiA-5ll7A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5GHY_A_CEDA301_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	6 / 12	SER A 70 SER A 130 ASN A 132 ASN A 170 LYS A 234 GLY A 236	6YV A 301 (-1.7A) 6YV A 301 (-2.6A) 6YV A 301 (-3.7A) 6YV A 301 (-2.9A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A)	0.55A	5ghyA-5ll7A: 42.2	5ghyA-5ll7A: 17.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5GHY_B_CEDB301_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	6 / 12	SER A 70 SER A 130 ASN A 132 ASN A 170 LYS A 234 GLY A 236	6YV A 301 (-1.7A) 6YV A 301 (-2.6A) 6YV A 301 (-3.7A) 6YV A 301 (-2.9A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A)	0.52A	5ghyB-5ll7A: 42.2	5ghyB-5ll7A: 17.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5GHZ_A_CEDA301_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	7 / 11	SER A 70 SER A 130 ASN A 132 ASN A 170 LYS A 234 THR A 235 GLY A 236	6YV A 301 (-1.7A) 6YV A 301 (-2.6A) 6YV A 301 (-3.7A) 6YV A 301 (-2.9A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A)	0.50A	5ghzA-5ll7A: 42.1	5ghzA-5ll7A: 17.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5GHZ_B_CEDB301_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	7 / 10	SER A 70 SER A 130 ASN A 132 ASN A 170 LYS A 234 THR A 235 GLY A 236	6YV A 301 (-1.7A) 6YV A 301 (-2.6A) 6YV A 301 (-3.7A) 6YV A 301 (-2.9A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A)	0.50A	5ghzB-5ll7A: 42.1	5ghzB-5ll7A: 17.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5KC4_E_RBFE201_1 (RIBOFLAVIN TRANSPORTER RIBU)	5ll7	BETA-LACTAMASE (Escherichia coli)	5 / 12	LEU A 169 GLY A 144 LEU A 76 ALA A 135 ASN A 136	None	1.29A	5kc4E-5ll7A: undetectable	5kc4E-5ll7A: 18.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LRB_A_ACRA1003_1 (ALPHA-1,4 GLUCAN PHOSPHORYLASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	4 / 6	PHE A 66 THR A 265 TYR A 264 PHE A 75	None	1.34A	5lrbA-5ll7A: undetectable	5lrbA-5ll7A: 7.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OJ0_A_9WTA801_0 (PENICILLIN-BINDING PROTEIN 2X)	5ll7	BETA-LACTAMASE (Escherichia coli)	5 / 12	SER A 130 ASN A 132 THR A 216 GLY A 236 THR A 237	6YV A 301 (-2.6A) 6YV A 301 (-3.7A) 6YV A 301 ( 4.2A) 6YV A 301 ( 4.0A) 6YV A 301 (-3.6A)	1.23A	5oj0A-5ll7A: 7.3	5oj0A-5ll7A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UXC_A_ZITA306_1 (PREDICTED AMINOGLYCOSIDE PHOSPHOTRANSFERASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	4 / 7	THR A 149 PHE A 72 ASP A 179 LEU A 169	EDO A 303 ( 4.9A) None None None	1.16A	5uxcA-5ll7A: undetectable	5uxcA-5ll7A: 15.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5W97_J_CHDJ101_1 (CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	5ll7	BETA-LACTAMASE (Escherichia coli)	4 / 5	ARG A 96 MET A 117 THR A 118 LEU A 122	None	1.38A	5w97J-5ll7A: undetectable	5w97J-5ll7A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5WAU_J_CHDJ101_1 (CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	5ll7	BETA-LACTAMASE (Escherichia coli)	4 / 5	ARG A 96 MET A 117 THR A 118 LEU A 122	None	1.34A	5wauJ-5ll7A: undetectable	5wauJ-5ll7A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YVN_A_ACTA305_0 (GLUTATHIONE S-TRANSFERASE OMEGA-1)	5ll7	BETA-LACTAMASE (Escherichia coli)	4 / 6	LEU A 169 LYS A 73 LEU A 76 LEU A 139	None 6YV A 301 ( 3.8A) None None	0.98A	5yvnA-5ll7A: undetectable	5yvnA-5ll7A: undetectable
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6B5Y_B_9F2B400_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	9 / 12	SER A 70 SER A 130 ASN A 170 THR A 216 ARG A 220 LYS A 234 THR A 235 GLY A 236 THR A 237	6YV A 301 (-1.7A) 6YV A 301 (-2.6A) 6YV A 301 (-2.9A) 6YV A 301 ( 4.2A) 6YV A 301 ( 3.7A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A) 6YV A 301 (-3.6A)	0.43A	6b5yB-5ll7A: 40.2	6b5yB-5ll7A: 40.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6B5Y_B_9F2B400_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	6 / 12	THR A 216 ARG A 220 LYS A 234 THR A 235 THR A 237 GLY A 239	6YV A 301 ( 4.2A) 6YV A 301 ( 3.7A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) None	0.82A	6b5yB-5ll7A: 40.2	6b5yB-5ll7A: 40.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6B5Y_D_9F2D400_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	9 / 12	SER A 70 SER A 130 ASN A 170 THR A 216 LYS A 234 THR A 235 GLY A 236 THR A 237 GLU A 276	6YV A 301 (-1.7A) 6YV A 301 (-2.6A) 6YV A 301 (-2.9A) 6YV A 301 ( 4.2A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A) 6YV A 301 (-3.6A) None	0.47A	6b5yD-5ll7A: 40.3	6b5yD-5ll7A: 40.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6B68_B_9F2B301_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	8 / 12	SER A 70 SER A 130 ASN A 170 THR A 216 LYS A 234 THR A 235 GLY A 236 THR A 237	6YV A 301 (-1.7A) 6YV A 301 (-2.6A) 6YV A 301 (-2.9A) 6YV A 301 ( 4.2A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A) 6YV A 301 (-3.6A)	0.36A	6b68B-5ll7A: 40.3	6b68B-5ll7A: 40.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6B68_D_9F2D400_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	9 / 12	SER A 70 SER A 130 ASN A 170 THR A 216 ARG A 220 LYS A 234 GLY A 236 THR A 237 GLU A 276	6YV A 301 (-1.7A) 6YV A 301 (-2.6A) 6YV A 301 (-2.9A) 6YV A 301 ( 4.2A) 6YV A 301 ( 3.7A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A) 6YV A 301 (-3.6A) None	0.38A	6b68D-5ll7A: 40.2	6b68D-5ll7A: 40.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6B69_B_9F2B301_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	8 / 12	SER A 70 SER A 130 ASN A 170 THR A 216 LYS A 234 THR A 235 GLY A 236 THR A 237	6YV A 301 (-1.7A) 6YV A 301 (-2.6A) 6YV A 301 (-2.9A) 6YV A 301 ( 4.2A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A) 6YV A 301 (-3.6A)	0.40A	6b69A-5ll7A: 40.2 6b69B-5ll7A: 40.2	6b69A-5ll7A: 40.00 6b69B-5ll7A: 40.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6B69_D_9F2D301_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	10 / 12	SER A 70 SER A 130 ASN A 170 THR A 216 ARG A 220 LYS A 234 THR A 235 GLY A 236 THR A 237 GLU A 276	6YV A 301 (-1.7A) 6YV A 301 (-2.6A) 6YV A 301 (-2.9A) 6YV A 301 ( 4.2A) 6YV A 301 ( 3.7A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A) 6YV A 301 (-3.6A) None	0.38A	6b69D-5ll7A: 40.1	6b69D-5ll7A: 40.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6B69_D_9F2D301_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	6 / 12	THR A 216 ARG A 220 THR A 235 THR A 237 GLY A 239 GLU A 276	6YV A 301 ( 4.2A) 6YV A 301 ( 3.7A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) None None	0.78A	6b69D-5ll7A: 40.1	6b69D-5ll7A: 40.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6B6A_B_9F2B301_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	9 / 12	SER A 70 SER A 130 ASN A 170 THR A 216 ARG A 220 LYS A 234 THR A 235 GLY A 236 THR A 237	6YV A 301 (-1.7A) 6YV A 301 (-2.6A) 6YV A 301 (-2.9A) 6YV A 301 ( 4.2A) 6YV A 301 ( 3.7A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A) 6YV A 301 (-3.6A)	0.36A	6b6aB-5ll7A: 40.3	6b6aB-5ll7A: 40.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6B6A_D_9F2D301_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	9 / 12	SER A 70 SER A 130 ASN A 170 ARG A 220 LYS A 234 THR A 235 GLY A 236 THR A 237 GLU A 276	6YV A 301 (-1.7A) 6YV A 301 (-2.6A) 6YV A 301 (-2.9A) 6YV A 301 ( 3.7A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A) 6YV A 301 (-3.6A) None	0.38A	6b6aD-5ll7A: 40.3	6b6aD-5ll7A: 40.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6B6C_A_9F2A301_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	8 / 12	SER A 70 SER A 130 ASN A 170 ARG A 220 LYS A 234 THR A 235 GLY A 236 THR A 237	6YV A 301 (-1.7A) 6YV A 301 (-2.6A) 6YV A 301 (-2.9A) 6YV A 301 ( 3.7A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A) 6YV A 301 (-3.6A)	0.47A	6b6cA-5ll7A: 40.0	6b6cA-5ll7A: 40.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6B6C_A_9F2A301_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	6 / 12	SER A 130 PRO A 104 ARG A 220 LYS A 234 THR A 235 THR A 237	6YV A 301 (-2.6A) None 6YV A 301 ( 3.7A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A)	1.34A	6b6cA-5ll7A: 40.0	6b6cA-5ll7A: 40.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6B6D_A_9F2A302_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	8 / 12	SER A 70 SER A 130 ASN A 170 THR A 216 LYS A 234 THR A 235 GLY A 236 THR A 237	6YV A 301 (-1.7A) 6YV A 301 (-2.6A) 6YV A 301 (-2.9A) 6YV A 301 ( 4.2A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A) 6YV A 301 (-3.6A)	0.40A	6b6dA-5ll7A: 40.0	6b6dA-5ll7A: 40.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6B6D_A_9F2A302_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	6 / 12	SER A 130 THR A 216 LYS A 234 THR A 235 THR A 237 GLY A 239	6YV A 301 (-2.6A) 6YV A 301 ( 4.2A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) None	0.87A	6b6dA-5ll7A: 40.0	6b6dA-5ll7A: 40.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6B6E_A_9F2A302_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	9 / 12	SER A 70 SER A 130 ASN A 170 THR A 216 ARG A 220 LYS A 234 THR A 235 GLY A 236 THR A 237	6YV A 301 (-1.7A) 6YV A 301 (-2.6A) 6YV A 301 (-2.9A) 6YV A 301 ( 4.2A) 6YV A 301 ( 3.7A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A) 6YV A 301 (-3.6A)	0.37A	6b6eA-5ll7A: 40.1	6b6eA-5ll7A: 40.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6B6F_A_9F2A301_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	8 / 12	CSS A 69 SER A 70 SER A 130 ASN A 170 LYS A 234 THR A 235 GLY A 236 THR A 237	None 6YV A 301 (-1.7A) 6YV A 301 (-2.6A) 6YV A 301 (-2.9A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A) 6YV A 301 (-3.6A)	0.61A	6b6fA-5ll7A: 39.6	6b6fA-5ll7A: 40.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BKL_G_EU7G101_0 (MATRIX PROTEIN 2)	5ll7	BETA-LACTAMASE (Escherichia coli)	5 / 9	ALA A 286 ALA A 262 ALA A 62 GLY A 45 SER A 59	None	1.15A	6bklE-5ll7A: undetectable 6bklF-5ll7A: undetectable 6bklG-5ll7A: undetectable 6bklH-5ll7A: undetectable	6bklE-5ll7A: undetectable 6bklF-5ll7A: undetectable 6bklG-5ll7A: undetectable 6bklH-5ll7A: undetectable
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6C79_A_CE3A301_1 (BETA-LACTAMASE TOHO-1)	5ll7	BETA-LACTAMASE (Escherichia coli)	6 / 12	SER A 130 ASN A 132 ASN A 170 THR A 216 LYS A 234 GLY A 236	6YV A 301 (-2.6A) 6YV A 301 (-3.7A) 6YV A 301 (-2.9A) 6YV A 301 ( 4.2A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A)	0.66A	6c79A-5ll7A: 43.3	6c79A-5ll7A: 33.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6C79_A_CE3A301_1 (BETA-LACTAMASE TOHO-1)	5ll7	BETA-LACTAMASE (Escherichia coli)	5 / 12	SER A 130 THR A 216 LYS A 234 GLY A 236 GLY A 239	6YV A 301 (-2.6A) 6YV A 301 ( 4.2A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A) None	0.92A	6c79A-5ll7A: 43.3	6c79A-5ll7A: 33.75

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1FKP_A_NVPA999_1","HIV-1 RT, A-CHAIN","5ll7","BETA-LACTAMASE","Escherichia coli",5,"LEU A 285;VAL A  46;VAL A  57;TYR A  60;LEU A  36","None","1.28A","1fkpA-5ll7A:undetectable","1fkpA-5ll7A:10.13"],["1FXH_B_PACB1001_0","PENICILLIN ACYLASE","5ll7","BETA-LACTAMASE","Escherichia coli",4,"PHE A 207;SER A 189;ALA A 198;ILE A 155","None;None;EDO A 302 (-3.5A);EDO A 302 (-4.3A)","1.05A","1fxhA-5ll7A:undetectable;1fxhB-5ll7A:undetectable","1fxhA-5ll7A:undetectable;1fxhB-5ll7A:undetectable"],["1GHM_A_CEDA1_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",6,"SER A  70;LYS A  73;SER A 130;ASN A 132;LYS A 234;GLY A 236","6YV A 301 (-1.7A);6YV A 301 ( 3.8A);6YV A 301 (-2.6A);6YV A 301 (-3.7A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A)","0.44A","1ghmA-5ll7A:37.7","1ghmA-5ll7A:13.89"],["1I2W_A_CFXA1300_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",8,"SER A  70;LYS A  73;SER A 130;ASN A 132;GLU A 166;THR A 216;LYS A 234;GLY A 236","6YV A 301 (-1.7A);6YV A 301 ( 3.8A);6YV A 301 (-2.6A);6YV A 301 (-3.7A);6YV A 301 (-2.7A);6YV A 301 ( 4.2A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A)","0.48A","1i2wA-5ll7A:41.5","1i2wA-5ll7A:18.62"],["1I2W_B_CFXB2300_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",7,"SER A  70;LYS A  73;SER A 130;ASN A 132;GLU A 166;GLY A 236;ARG A 220","6YV A 301 (-1.7A);6YV A 301 ( 3.8A);6YV A 301 (-2.6A);6YV A 301 (-3.7A);6YV A 301 (-2.7A);6YV A 301 ( 4.0A);6YV A 301 ( 3.7A)","1.07A","1i2wB-5ll7A:41.8","1i2wB-5ll7A:18.62"],["1I2W_B_CFXB2300_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",7,"SER A  70;LYS A  73;SER A 130;ASN A 132;GLU A 166;THR A 216;GLY A 236","6YV A 301 (-1.7A);6YV A 301 ( 3.8A);6YV A 301 (-2.6A);6YV A 301 (-3.7A);6YV A 301 (-2.7A);6YV A 301 ( 4.2A);6YV A 301 ( 4.0A)","0.44A","1i2wB-5ll7A:41.8","1i2wB-5ll7A:18.62"],["1S1X_A_NVPA999_1","REVERSE TRANSCRIPTASE","5ll7","BETA-LACTAMASE","Escherichia coli",4,"LEU A  36;VAL A  46;GLY A  45;LEU A 285","None","0.81A","1s1xA-5ll7A:undetectable","1s1xA-5ll7A:10.05"],["1YMX_A_CFXA1001_1","BETA-LACTAMASE CTX-M-9","5ll7","BETA-LACTAMASE","Escherichia coli",9,"SER A  70;LYS A  73;SER A 130;ASN A 132;GLU A 166;ASN A 170;THR A 216;LYS A 234;GLY A 236","6YV A 301 (-1.7A);6YV A 301 ( 3.8A);6YV A 301 (-2.6A);6YV A 301 (-3.7A);6YV A 301 (-2.7A);6YV A 301 (-2.9A);6YV A 301 ( 4.2A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A)","0.71A","1ymxA-5ll7A:42.9","1ymxA-5ll7A:17.00"],["1YMX_B_CFXB1002_1","BETA-LACTAMASE CTX-M-9","5ll7","BETA-LACTAMASE","Escherichia coli",8,"SER A  70;LYS A  73;SER A 130;ASN A 132;GLU A 166;ASN A 170;LYS A 234;GLY A 236","6YV A 301 (-1.7A);6YV A 301 ( 3.8A);6YV A 301 (-2.6A);6YV A 301 (-3.7A);6YV A 301 (-2.7A);6YV A 301 (-2.9A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A)","0.68A","1ymxB-5ll7A:43.1","1ymxB-5ll7A:17.00"],["2CIZ_A_ACTA1320_0","CHLOROPEROXIDASE","5ll7","BETA-LACTAMASE","Escherichia coli",4,"ALA A 286;PHE A  33;ILE A  44;VAL A 263","None","0.97A","2cizA-5ll7A:undetectable","2cizA-5ll7A:undetectable"],["2EIM_J_CHDJ60_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART","5ll7","BETA-LACTAMASE","Escherichia coli",4,"ARG A  96;MET A 117;THR A 118;LEU A 122","None","1.31A","2eimJ-5ll7A:undetectable","2eimJ-5ll7A:undetectable"],["2EIM_W_CHDW1060_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART","5ll7","BETA-LACTAMASE","Escherichia coli",4,"ARG A  96;MET A 117;THR A 118;LEU A 122","None","1.35A","2eimW-5ll7A:undetectable","2eimW-5ll7A:undetectable"],["2VCV_D_ASDD1224_1","GLUTATHIONE S-TRANSFERASE A3","5ll7","BETA-LACTAMASE","Escherichia coli",5,"PRO A 145;LEU A 162;LEU A 139;ALA A 135;PHE A  72","None","1.13A","2vcvD-5ll7A:undetectable","2vcvD-5ll7A:17.24"],["2VCV_E_ASDE1224_1","GLUTATHIONE S-TRANSFERASE A3","5ll7","BETA-LACTAMASE","Escherichia coli",5,"PRO A 145;LEU A 162;LEU A 139;ALA A 135;PHE A  72","None","1.09A","2vcvE-5ll7A:undetectable","2vcvE-5ll7A:17.24"],["2VCV_H_ASDH1224_1","GLUTATHIONE S-TRANSFERASE A3","5ll7","BETA-LACTAMASE","Escherichia coli",5,"PRO A 145;LEU A 162;LEU A 139;ALA A 135;PHE A  72","None","1.07A","2vcvH-5ll7A:undetectable","2vcvH-5ll7A:17.24"],["3CLB_B_TMQB612_1","DHFR-TS","5ll7","BETA-LACTAMASE","Escherichia coli",5,"ALA A 185;ASP A 157;MET A 152;PHE A 160;TYR A 264","None","1.18A","3clbB-5ll7A:undetectable","3clbB-5ll7A:11.00"],["3HLW_A_CE3A301_1","CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",7,"LYS A  73;SER A 130;ASN A 132;ASN A 170;THR A 216;LYS A 234;GLY A 236","6YV A 301 ( 3.8A);6YV A 301 (-2.6A);6YV A 301 (-3.7A);6YV A 301 (-2.9A);6YV A 301 ( 4.2A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A)","0.72A","3hlwA-5ll7A:43.0","3hlwA-5ll7A:16.60"],["3HLW_B_CE3B302_1","CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",7,"SER A 130;ASN A 132;ASN A 170;THR A 216;LYS A 234;THR A 235;GLY A 236","6YV A 301 (-2.6A);6YV A 301 (-3.7A);6YV A 301 (-2.9A);6YV A 301 ( 4.2A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A)","0.66A","3hlwB-5ll7A:43.0","3hlwB-5ll7A:16.60"],["3HUO_A_PNNA300_0","CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",6,"LYS A  73;ASN A 132;ASN A 170;LYS A 234;THR A 235;GLY A 236","6YV A 301 ( 3.8A);6YV A 301 (-3.7A);6YV A 301 (-2.9A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A)","0.58A","3huoA-5ll7A:42.8","3huoA-5ll7A:undetectable"],["3HUO_A_PNNA302_0","CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",5,"THR A  51;LEU A 195;GLY A 196;ALA A 257;PRO A 258","None","0.24A","3huoA-5ll7A:42.8","3huoA-5ll7A:undetectable"],["3HUO_B_PNNB301_0","CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",5,"LYS A  73;ASN A 132;ASN A 170;LYS A 234;GLY A 236","6YV A 301 ( 3.8A);6YV A 301 (-3.7A);6YV A 301 (-2.9A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A)","0.58A","3huoB-5ll7A:42.9","3huoB-5ll7A:undetectable"],["3MZE_A_CFXA364_1","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE DACA","5ll7","BETA-LACTAMASE","Escherichia coli",6,"SER A  70;ASN A 132;LEU A 167;THR A 235;GLY A 236;ARG A 220","6YV A 301 (-1.7A);6YV A 301 (-3.7A);None;6YV A 301 (-3.6A);6YV A 301 ( 4.0A);6YV A 301 ( 3.7A)","0.87A","3mzeA-5ll7A:21.3","3mzeA-5ll7A:11.85"],["3MZE_A_CFXA364_1","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE DACA","5ll7","BETA-LACTAMASE","Escherichia coli",6,"SER A  70;LYS A  73;ASN A 132;THR A 235;GLY A 236;ARG A 220","6YV A 301 (-1.7A);6YV A 301 ( 3.8A);6YV A 301 (-3.7A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A);6YV A 301 ( 3.7A)","0.73A","3mzeA-5ll7A:21.3","3mzeA-5ll7A:11.85"],["3NY4_A_SMXA308_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",9,"SER A  70;SER A 130;ASN A 170;THR A 216;ARG A 220;LYS A 234;THR A 235;GLY A 236;THR A 237","6YV A 301 (-1.7A);6YV A 301 (-2.6A);6YV A 301 (-2.9A);6YV A 301 ( 4.2A);6YV A 301 ( 3.7A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A);6YV A 301 (-3.6A)","0.30A","3ny4A-5ll7A:39.9","3ny4A-5ll7A:19.38"],["3Q07_A_WPPA300_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",6,"LYS A  73;SER A 130;ASN A 132;ASN A 170;LYS A 234;GLY A 236","6YV A 301 ( 3.8A);6YV A 301 (-2.6A);6YV A 301 (-3.7A);6YV A 301 (-2.9A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A)","0.62A","3q07A-5ll7A:42.8","3q07A-5ll7A:16.60"],["3Q07_B_WPPB400_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",6,"LYS A  73;SER A 130;ASN A 132;ASN A 170;LYS A 234;GLY A 236","6YV A 301 ( 3.8A);6YV A 301 (-2.6A);6YV A 301 (-3.7A);6YV A 301 (-2.9A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A)","0.60A","3q07B-5ll7A:43.0","3q07B-5ll7A:16.60"],["3SH8_A_CEDA1_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",6,"SER A  70;SER A 130;ASN A 132;LYS A 234;THR A 235;GLY A 236","6YV A 301 (-1.7A);6YV A 301 (-2.6A);6YV A 301 (-3.7A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A)","0.49A","3sh8A-5ll7A:40.6","3sh8A-5ll7A:17.30"],["3SH8_B_CEDB1_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",6,"SER A  70;LYS A  73;SER A 130;ASN A 132;LYS A 234;GLY A 236","6YV A 301 (-1.7A);6YV A 301 ( 3.8A);6YV A 301 (-2.6A);6YV A 301 (-3.7A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A)","0.58A","3sh8B-5ll7A:40.2","3sh8B-5ll7A:17.30"],["4EUZ_A_MEMA401_1","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","5ll7","BETA-LACTAMASE","Escherichia coli",10,"LYS A  73;SER A 130;ASN A 132;LEU A 167;ASN A 170;THR A 216;LYS A 234;THR A 235;GLY A 236;THR A 237","6YV A 301 ( 3.8A);6YV A 301 (-2.6A);6YV A 301 (-3.7A);None;6YV A 301 (-2.9A);6YV A 301 ( 4.2A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A);6YV A 301 (-3.6A)","0.45A","4euzA-5ll7A:45.4","4euzA-5ll7A:22.54"],["4FH2_A_0RNA303_1","BETA-LACTAMASE SHV-1","5ll7","BETA-LACTAMASE","Escherichia coli",5,"SER A 130;ASN A 132;LYS A 234;THR A 235;GLY A 236","6YV A 301 (-2.6A);6YV A 301 (-3.7A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A)","0.41A","4fh2A-5ll7A:35.2","4fh2A-5ll7A:16.80"],["4KCN_B_MTLB805_0","NITRIC OXIDE SYNTHASE, BRAIN","5ll7","BETA-LACTAMASE","Escherichia coli",4,"ARG A 161;ASP A 176;ASP A 163;ARG A 178","None","1.39A","4kcnB-5ll7A:undetectable","4kcnB-5ll7A:undetectable"],["4LB2_A_DM5A601_1","SERUM ALBUMIN","5ll7","BETA-LACTAMASE","Escherichia coli",4,"LEU A 122;VAL A 119;PRO A  94;TYR A 112","None","1.01A","4lb2A-5ll7A:undetectable","4lb2A-5ll7A:9.15"],["4N9K_A_CEDA301_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",7,"SER A  70;SER A 130;ASN A 132;ASN A 170;LYS A 234;THR A 235;GLY A 236","6YV A 301 (-1.7A);6YV A 301 (-2.6A);6YV A 301 (-3.7A);6YV A 301 (-2.9A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A)","0.50A","4n9kA-5ll7A:42.0","4n9kA-5ll7A:17.57"],["4N9K_B_CEDB301_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",7,"SER A  70;SER A 130;ASN A 132;ASN A 170;LYS A 234;THR A 235;GLY A 236","6YV A 301 (-1.7A);6YV A 301 (-2.6A);6YV A 301 (-3.7A);6YV A 301 (-2.9A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A)","0.48A","4n9kB-5ll7A:42.0","4n9kB-5ll7A:17.57"],["4PB1_A_RBVA501_1","NUPC FAMILY PROTEIN","5ll7","BETA-LACTAMASE","Escherichia coli",5,"GLY A  74;ALA A  77;LEU A 148;ASN A 136;ASN A 132","None;None;None;None;6YV A 301 (-3.7A)","1.37A","4pb1A-5ll7A:undetectable","4pb1A-5ll7A:13.41"],["4PM5_A_CE3A301_1","BETA-LACTAMASE CTX-M-14","5ll7","BETA-LACTAMASE","Escherichia coli",7,"SER A 130;ASN A 132;ASN A 170;THR A 216;LYS A 234;THR A 235;GLY A 236","6YV A 301 (-2.6A);6YV A 301 (-3.7A);6YV A 301 (-2.9A);6YV A 301 ( 4.2A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A)","0.65A","4pm5A-5ll7A:43.1","4pm5A-5ll7A:16.60"],["4PM5_A_CE3A301_1","BETA-LACTAMASE CTX-M-14","5ll7","BETA-LACTAMASE","Escherichia coli",6,"SER A 130;THR A 216;LYS A 234;THR A 235;GLY A 236;GLY A 239","6YV A 301 (-2.6A);6YV A 301 ( 4.2A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A);None","0.88A","4pm5A-5ll7A:43.1","4pm5A-5ll7A:16.60"],["4PM7_A_CE3A301_1","BETA-LACTAMASE CTX-M-14","5ll7","BETA-LACTAMASE","Escherichia coli",7,"LYS A  73;SER A 130;ASN A 132;ASN A 170;THR A 216;LYS A 234;GLY A 236","6YV A 301 ( 3.8A);6YV A 301 (-2.6A);6YV A 301 (-3.7A);6YV A 301 (-2.9A);6YV A 301 ( 4.2A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A)","0.71A","4pm7A-5ll7A:43.0","4pm7A-5ll7A:16.60"],["4PM9_A_CE3A301_1","BETA-LACTAMASE CTX-M-14","5ll7","BETA-LACTAMASE","Escherichia coli",7,"SER A 130;ASN A 132;ASN A 170;THR A 216;LYS A 234;THR A 235;GLY A 236","6YV A 301 (-2.6A);6YV A 301 (-3.7A);6YV A 301 (-2.9A);6YV A 301 ( 4.2A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A)","0.63A","4pm9A-5ll7A:42.6","4pm9A-5ll7A:16.60"],["4Q0B_C_NVPC901_1","HIV-1 REVERSE TRANSCRIPTASE, P66 SUBUNIT","5ll7","BETA-LACTAMASE","Escherichia coli",5,"LEU A 285;VAL A  46;VAL A  57;TYR A  60;LEU A  36","None","1.32A","4q0bC-5ll7A:undetectable","4q0bC-5ll7A:9.32"],["4ZXI_A_GLYA1402_0","TYROCIDINE SYNTHETASE 3","5ll7","BETA-LACTAMASE","Escherichia coli",4,"ASP A 246;ILE A 221;GLY A 232;THR A 235","None;None;None;6YV A 301 (-3.6A)","1.16A","4zxiA-5ll7A:undetectable","4zxiA-5ll7A:undetectable"],["5GHY_A_CEDA301_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",6,"SER A  70;SER A 130;ASN A 132;ASN A 170;LYS A 234;GLY A 236","6YV A 301 (-1.7A);6YV A 301 (-2.6A);6YV A 301 (-3.7A);6YV A 301 (-2.9A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A)","0.55A","5ghyA-5ll7A:42.2","5ghyA-5ll7A:17.57"],["5GHY_B_CEDB301_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",6,"SER A  70;SER A 130;ASN A 132;ASN A 170;LYS A 234;GLY A 236","6YV A 301 (-1.7A);6YV A 301 (-2.6A);6YV A 301 (-3.7A);6YV A 301 (-2.9A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A)","0.52A","5ghyB-5ll7A:42.2","5ghyB-5ll7A:17.57"],["5GHZ_A_CEDA301_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",7,"SER A  70;SER A 130;ASN A 132;ASN A 170;LYS A 234;THR A 235;GLY A 236","6YV A 301 (-1.7A);6YV A 301 (-2.6A);6YV A 301 (-3.7A);6YV A 301 (-2.9A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A)","0.50A","5ghzA-5ll7A:42.1","5ghzA-5ll7A:17.57"],["5GHZ_B_CEDB301_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",7,"SER A  70;SER A 130;ASN A 132;ASN A 170;LYS A 234;THR A 235;GLY A 236","6YV A 301 (-1.7A);6YV A 301 (-2.6A);6YV A 301 (-3.7A);6YV A 301 (-2.9A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A)","0.50A","5ghzB-5ll7A:42.1","5ghzB-5ll7A:17.57"],["5KC4_E_RBFE201_1","RIBOFLAVIN TRANSPORTER RIBU","5ll7","BETA-LACTAMASE","Escherichia coli",5,"LEU A 169;GLY A 144;LEU A  76;ALA A 135;ASN A 136","None","1.29A","5kc4E-5ll7A:undetectable","5kc4E-5ll7A:18.34"],["5LRB_A_ACRA1003_1","ALPHA-1,4 GLUCAN PHOSPHORYLASE","5ll7","BETA-LACTAMASE","Escherichia coli",4,"PHE A  66;THR A 265;TYR A 264;PHE A  75","None","1.34A","5lrbA-5ll7A:undetectable","5lrbA-5ll7A:7.31"],["5OJ0_A_9WTA801_0","PENICILLIN-BINDING PROTEIN 2X","5ll7","BETA-LACTAMASE","Escherichia coli",5,"SER A 130;ASN A 132;THR A 216;GLY A 236;THR A 237","6YV A 301 (-2.6A);6YV A 301 (-3.7A);6YV A 301 ( 4.2A);6YV A 301 ( 4.0A);6YV A 301 (-3.6A)","1.23A","5oj0A-5ll7A:7.3","5oj0A-5ll7A:undetectable"],["5UXC_A_ZITA306_1","PREDICTED AMINOGLYCOSIDE PHOSPHOTRANSFERASE","5ll7","BETA-LACTAMASE","Escherichia coli",4,"THR A 149;PHE A  72;ASP A 179;LEU A 169","EDO A 303 ( 4.9A);None;None;None","1.16A","5uxcA-5ll7A:undetectable","5uxcA-5ll7A:15.82"],["5W97_J_CHDJ101_1","CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","5ll7","BETA-LACTAMASE","Escherichia coli",4,"ARG A  96;MET A 117;THR A 118;LEU A 122","None","1.38A","5w97J-5ll7A:undetectable","5w97J-5ll7A:undetectable"],["5WAU_J_CHDJ101_1","CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","5ll7","BETA-LACTAMASE","Escherichia coli",4,"ARG A  96;MET A 117;THR A 118;LEU A 122","None","1.34A","5wauJ-5ll7A:undetectable","5wauJ-5ll7A:undetectable"],["5YVN_A_ACTA305_0","GLUTATHIONE S-TRANSFERASE OMEGA-1","5ll7","BETA-LACTAMASE","Escherichia coli",4,"LEU A 169;LYS A  73;LEU A  76;LEU A 139","None;6YV A 301 ( 3.8A);None;None","0.98A","5yvnA-5ll7A:undetectable","5yvnA-5ll7A:undetectable"],["6B5Y_B_9F2B400_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",9,"SER A  70;SER A 130;ASN A 170;THR A 216;ARG A 220;LYS A 234;THR A 235;GLY A 236;THR A 237","6YV A 301 (-1.7A);6YV A 301 (-2.6A);6YV A 301 (-2.9A);6YV A 301 ( 4.2A);6YV A 301 ( 3.7A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A);6YV A 301 (-3.6A)","0.43A","6b5yB-5ll7A:40.2","6b5yB-5ll7A:40.00"],["6B5Y_B_9F2B400_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",6,"THR A 216;ARG A 220;LYS A 234;THR A 235;THR A 237;GLY A 239","6YV A 301 ( 4.2A);6YV A 301 ( 3.7A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);None","0.82A","6b5yB-5ll7A:40.2","6b5yB-5ll7A:40.00"],["6B5Y_D_9F2D400_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",9,"SER A  70;SER A 130;ASN A 170;THR A 216;LYS A 234;THR A 235;GLY A 236;THR A 237;GLU A 276","6YV A 301 (-1.7A);6YV A 301 (-2.6A);6YV A 301 (-2.9A);6YV A 301 ( 4.2A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A);6YV A 301 (-3.6A);None","0.47A","6b5yD-5ll7A:40.3","6b5yD-5ll7A:40.00"],["6B68_B_9F2B301_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",8,"SER A  70;SER A 130;ASN A 170;THR A 216;LYS A 234;THR A 235;GLY A 236;THR A 237","6YV A 301 (-1.7A);6YV A 301 (-2.6A);6YV A 301 (-2.9A);6YV A 301 ( 4.2A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A);6YV A 301 (-3.6A)","0.36A","6b68B-5ll7A:40.3","6b68B-5ll7A:40.00"],["6B68_D_9F2D400_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",9,"SER A  70;SER A 130;ASN A 170;THR A 216;ARG A 220;LYS A 234;GLY A 236;THR A 237;GLU A 276","6YV A 301 (-1.7A);6YV A 301 (-2.6A);6YV A 301 (-2.9A);6YV A 301 ( 4.2A);6YV A 301 ( 3.7A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A);6YV A 301 (-3.6A);None","0.38A","6b68D-5ll7A:40.2","6b68D-5ll7A:40.00"],["6B69_B_9F2B301_1","BETA-LACTAMASE;BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",8,"SER A  70;SER A 130;ASN A 170;THR A 216;LYS A 234;THR A 235;GLY A 236;THR A 237","6YV A 301 (-1.7A);6YV A 301 (-2.6A);6YV A 301 (-2.9A);6YV A 301 ( 4.2A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A);6YV A 301 (-3.6A)","0.40A","6b69A-5ll7A:40.2;6b69B-5ll7A:40.2","6b69A-5ll7A:40.00;6b69B-5ll7A:40.00"],["6B69_D_9F2D301_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",10,"SER A  70;SER A 130;ASN A 170;THR A 216;ARG A 220;LYS A 234;THR A 235;GLY A 236;THR A 237;GLU A 276","6YV A 301 (-1.7A);6YV A 301 (-2.6A);6YV A 301 (-2.9A);6YV A 301 ( 4.2A);6YV A 301 ( 3.7A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A);6YV A 301 (-3.6A);None","0.38A","6b69D-5ll7A:40.1","6b69D-5ll7A:40.00"],["6B69_D_9F2D301_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",6,"THR A 216;ARG A 220;THR A 235;THR A 237;GLY A 239;GLU A 276","6YV A 301 ( 4.2A);6YV A 301 ( 3.7A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);None;None","0.78A","6b69D-5ll7A:40.1","6b69D-5ll7A:40.00"],["6B6A_B_9F2B301_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",9,"SER A  70;SER A 130;ASN A 170;THR A 216;ARG A 220;LYS A 234;THR A 235;GLY A 236;THR A 237","6YV A 301 (-1.7A);6YV A 301 (-2.6A);6YV A 301 (-2.9A);6YV A 301 ( 4.2A);6YV A 301 ( 3.7A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A);6YV A 301 (-3.6A)","0.36A","6b6aB-5ll7A:40.3","6b6aB-5ll7A:40.00"],["6B6A_D_9F2D301_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",9,"SER A  70;SER A 130;ASN A 170;ARG A 220;LYS A 234;THR A 235;GLY A 236;THR A 237;GLU A 276","6YV A 301 (-1.7A);6YV A 301 (-2.6A);6YV A 301 (-2.9A);6YV A 301 ( 3.7A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A);6YV A 301 (-3.6A);None","0.38A","6b6aD-5ll7A:40.3","6b6aD-5ll7A:40.00"],["6B6C_A_9F2A301_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",8,"SER A  70;SER A 130;ASN A 170;ARG A 220;LYS A 234;THR A 235;GLY A 236;THR A 237","6YV A 301 (-1.7A);6YV A 301 (-2.6A);6YV A 301 (-2.9A);6YV A 301 ( 3.7A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A);6YV A 301 (-3.6A)","0.47A","6b6cA-5ll7A:40.0","6b6cA-5ll7A:40.00"],["6B6C_A_9F2A301_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",6,"SER A 130;PRO A 104;ARG A 220;LYS A 234;THR A 235;THR A 237","6YV A 301 (-2.6A);None;6YV A 301 ( 3.7A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 (-3.6A)","1.34A","6b6cA-5ll7A:40.0","6b6cA-5ll7A:40.00"],["6B6D_A_9F2A302_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",8,"SER A  70;SER A 130;ASN A 170;THR A 216;LYS A 234;THR A 235;GLY A 236;THR A 237","6YV A 301 (-1.7A);6YV A 301 (-2.6A);6YV A 301 (-2.9A);6YV A 301 ( 4.2A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A);6YV A 301 (-3.6A)","0.40A","6b6dA-5ll7A:40.0","6b6dA-5ll7A:40.00"],["6B6D_A_9F2A302_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",6,"SER A 130;THR A 216;LYS A 234;THR A 235;THR A 237;GLY A 239","6YV A 301 (-2.6A);6YV A 301 ( 4.2A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);None","0.87A","6b6dA-5ll7A:40.0","6b6dA-5ll7A:40.00"],["6B6E_A_9F2A302_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",9,"SER A  70;SER A 130;ASN A 170;THR A 216;ARG A 220;LYS A 234;THR A 235;GLY A 236;THR A 237","6YV A 301 (-1.7A);6YV A 301 (-2.6A);6YV A 301 (-2.9A);6YV A 301 ( 4.2A);6YV A 301 ( 3.7A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A);6YV A 301 (-3.6A)","0.37A","6b6eA-5ll7A:40.1","6b6eA-5ll7A:40.00"],["6B6F_A_9F2A301_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",8,"CSS A  69;SER A  70;SER A 130;ASN A 170;LYS A 234;THR A 235;GLY A 236;THR A 237","None;6YV A 301 (-1.7A);6YV A 301 (-2.6A);6YV A 301 (-2.9A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A);6YV A 301 (-3.6A)","0.61A","6b6fA-5ll7A:39.6","6b6fA-5ll7A:40.00"],["6BKL_G_EU7G101_0","MATRIX PROTEIN 2","5ll7","BETA-LACTAMASE","Escherichia coli",5,"ALA A 286;ALA A 262;ALA A  62;GLY A  45;SER A  59","None","1.15A","6bklE-5ll7A:undetectable;6bklF-5ll7A:undetectable;6bklG-5ll7A:undetectable;6bklH-5ll7A:undetectable","6bklE-5ll7A:undetectable;6bklF-5ll7A:undetectable;6bklG-5ll7A:undetectable;6bklH-5ll7A:undetectable"],["6C79_A_CE3A301_1","BETA-LACTAMASE TOHO-1","5ll7","BETA-LACTAMASE","Escherichia coli",6,"SER A 130;ASN A 132;ASN A 170;THR A 216;LYS A 234;GLY A 236","6YV A 301 (-2.6A);6YV A 301 (-3.7A);6YV A 301 (-2.9A);6YV A 301 ( 4.2A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A)","0.66A","6c79A-5ll7A:43.3","6c79A-5ll7A:33.75"],["6C79_A_CE3A301_1","BETA-LACTAMASE TOHO-1","5ll7","BETA-LACTAMASE","Escherichia coli",5,"SER A 130;THR A 216;LYS A 234;GLY A 236;GLY A 239","6YV A 301 (-2.6A);6YV A 301 ( 4.2A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A);None","0.92A","6c79A-5ll7A:43.3","6c79A-5ll7A:33.75"]]